Successful trial for Gilead Coronavirus Drug. A majority of patients hospitalized with severe coronavirus symptom showed clinical improvements following compassionate…
Read MoreTakeda Developing Plasma Therapy for COVID-19 Patients. Takeda is developing a plasma-derived hyperimmune globulin therapy for COVID-19. TAK-888 could be…
Read MoreRealigning healthcare facilities for COVID-19 patients. The former Cone Health Women’s Hospital opened April 13 to care for severely ill…
Read MoreEngineers Maximizing National Stockpile Equipment.Engineers from UW Health and University of Wisconsin-Madison Engineering teamed to design and test a prototype…
Read MoreLabCorp performing more than 20,000 COVID-19 tests per day. LabCorp was able to double its COVID-19 testing capacity in one…
Read MoreUW Hospital to test convalescent plasma treatment of COVID-19 patients. Early next week, UW Hospital will transfuse antibodies from the…
Read MoreAmgen in partnership to develop therapeutic to prevent or treat COVID-19. Amgen has begun an immediate collaboration with Adaptive Biotechnologies…
Read MoreMedical face shield developed from idea to production in a few days.The team of UW-Madison Engineering and Madison’s Delve Design…
Read MoreDesigning for infectious disease and COVID-19 research. AEI principal Laura Halverson discusses transitioning an NIH-funded lab concept for high pathogen…
Read MoreZeroing in on COVID-19, locally and globally. Established a month before the first community transmission of COVID-19 in the state…
Read MorePromega ramping up production of testing materials to address COVID-19 outbreak. Promega Corp. has sharply increased production of lab materials…
Read MoreUW-Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine. Virologists at the University of Wisconsin – Madison and vaccine…
Read More